Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C800156200 on August 13, 2008

J. Biol. Chem., Vol. 283, Issue 40, 26834-26838, October 3, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow An addition or correction has been published
Right arrow All Versions of this Article:
283/40/26834    most recent
C800156200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anzai, N.
Right arrow Articles by Sakurai, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anzai, N.
Right arrow Articles by Sakurai, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans*Formula

Naohiko Anzai{ddagger}1, Kimiyoshi Ichida§, Promsuk Jutabha, Toru Kimura{ddagger}, Ellappan Babu{ddagger}, Chun Ji Jin{ddagger}, Sunena Srivastava{ddagger}, Kenichiro Kitamura||, Ichiro Hisatome**, Hitoshi Endou{ddagger}{ddagger}{ddagger}, and Hiroyuki Sakurai{ddagger}

From the {ddagger}Department of Pharmacology and Toxicology, Kyorin University School of Medicine, 181-8611 Tokyo, the §Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, 192-0392 Tokyo, the Kobuchisawa Research Laboratories, Fuji Biomedix Co. Ltd., 408-0044 Yamanashi, the ||Department of Nephrology, Kumamoto University Graduate School of Medical and Pharmaceutical Sciences, 860-8556 Kumamoto, the **Department of Cardiovascular Medicine, Tottori University Faculty of Medicine, 680-8550 Tottori, and the {ddagger}{ddagger}J-Pharma Co. Ltd., 160-0022 Tokyo, Japan

Hyperuricemia is a significant factor in a variety of diseases, including gout and cardiovascular diseases. Although renal excretion largely determines plasma urate concentration, the molecular mechanism of renal urate handling remains elusive. Previously, we identified a major urate reabsorptive transporter, URAT1 (SLC22A12), on the apical side of the renal proximal tubular cells. However, it is not known how urate taken up by URAT1 exits from the tubular cell to the systemic circulation. Here, we report that a sugar transport facilitator family member protein GLUT9 (SLC2A9) functions as an efflux transporter of urate from the tubular cell. GLUT9-expressed Xenopus oocytes mediated saturable urate transport (Km: 365 ± 42 µM). The transport was Na+-independent and enhanced at high concentrations of extracellular potassium favoring negative to positive potential direction. Substrate specificity and pyrazinoate sensitivity of GLUT9 was distinct from those of URAT1. The in vivo role of GLUT9 is supported by the fact that a renal hypouricemia patient without any mutations in SLC22A12 was found to have a missense mutation in SLC2A9, which reduced urate transport activity in vitro. Based on these data, we propose a novel model of transcellular urate transport in the kidney; Remunurate is taken up via apically located URAT1 and exits the cell via basolaterally located GLUT9, which we suggest be renamed URATv1 (voltage-driven urate transporter 1).


Received for publication, August 6, 2008

* This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society for the Promotion of Science, the Takeda Science Foundation, the Salt Science Research Foundation (Grant 0721), the Gout Research Foundation of Japan, and the Shimabara Foundation and Kyorin University School of Medicine (Collaborative Project 2008). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains three supplemental figures and supplemental text.

1 To whom correspondence should be addressed: 6-20-2, Shinkawa, Mitakashi, Tokyo 181-8611, Japan. Tel.: 81-422-47-5511; Fax: 81-422-79-1321; E-mail: anzai{at}ks.kyorin-u.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
N. Dalbeth and T. Merriman
Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout
Rheumatology, March 1, 2009; 48(3): 222 - 226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. M. Bataille, J. Goldmeyer, and J. L. Renfro
Avian renal proximal tubule epithelium urate secretion is mediated by Mrp4
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R2024 - R2033.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement